A recent study by Yang et al. has revealed MET fusions in solid tumors from a multicenter study in China, indicating its incidence with 0.34% (37/10882) across cancer types and 0.07% (4/5835) in LC,35 which were 0.15% (122/79803) and 0.16% (92/57863) in the present study. This evidence concerns the gene MET and cancer.